For any questions or inquiries, please feel free to contact us.
ARENSIA Innovative Spotlight Session, May 16th, San Francisco, CA
We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize ...
ARENSIA Spotlight Session, November 07th, Boston, MA
We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-...
ARENSIA Opening a new Clinical Research Unit for multi-therapeutic indications Kiev, Ukraine
As consequence of the increasing demand for ARENSIA´s capabilities as a specialist for early clinical trials in pa...
ARENSIA Spotlight Session, May 24th, San Francisco, CA
We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-...
ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.
MORE
ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.
MORE
ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.
MOREARENSIA Exploratory Medicine GmbH
Merowingerplatz 1
40225 Duesseldorf
Germany
Legal Representatives
Geschaeftsfuehrer / Managing Director: Dr. Claudia Hesselmann / Dr. Jochen Kraatz
Amtsgericht / Local Court: Düsseldorf, HRB 64937
Umsatzsteuer-Identifikationsnummer gemäß §27a Umsatzsteuergesetz: DE 27629 5755